No. 2179 March 8, 2010
PHARMA JAPAN is a must read for every busy executive who needs to keep up with the world's second largest health care market.
P. Reed Maurer
 　　　　　　　　　　　　
BMKK to Break from Long-Listed Drugs: Mr Wright
 p 1
Takeda to Shore Up Lifestyle Diseases Area in Japan with New Products
 p 2
Astellas Begins Tender Offer to Acquire OSI Pharmaceuticals p 4
Shionogi Licenses Ospemifene from QuatRx p 5
9 Products, Including Pfizer's Lyrica, Recommended for Approvalp 10
Korosho to Call on Public Hospitals for Earlier Price Settlement p 13
Daiichi Sankyo to Embark on Generics Business in Japan p 17
Astellas Licenses Isavuconazole from Basilea p 18
Legislation of "Specific Nurses" Proposed by Korosho p 21

PHARMA JAPAN witnesses important events taking place in the second-largest pharmaceutical market on a comprehensive, weekly basis.



│Information│Order Here│Preview│Ads│Table of Contents│Books│